Literature DB >> 1627186

In vitro activity of sertaconazole.

C Palacín1, A Sacristán, J A Ortiz.   

Abstract

The activity of 7-chloro-3-[1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl) ethoxy-methyl]benzo[b]thiophene (sertaconazole, FI 7045, CAS 99592-32-2), a new topical antifungal, was studied in vitro against several infecting organisms. The results obtained show that sertaconazole is a broad-spectrum antifungal against yeasts (C. albicans, C. tropicalis, C. pseudotropicalis, C. krusei, Trichosporon and Cryptococcus), dermatophytes (Microsporum, Trichophyton and Epidermophyton), opportunistic filamentous fungi (Aspergillus) and Gram-positive bacteria. The MIC (minimum inhibitory concentration) values for the fungistatic activity were between 0.35 and 5.04 micrograms/ml for yeasts and between 0.24 and 2 micrograms/ml for dermatophytes; even partial activities (IC25) against these organisms were obtained at concentrations 10 times lower than those mentioned. At concentrations superior to MIC (MFC between 0.5 and 16 micrograms/ml), sertaconazole exhibited fungicidal activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627186

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis.

Authors:  Alfonso J Carrillo-Muñoz; Cristina Tur-Tur; Delia C Cárdenes; Dolors Estivill; Gustavo Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

2.  Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of tinea corporis-an observational study.

Authors:  Raghu Prasada Malladar Shivamurthy; Shashikala Gowdara Hanumantappa Reddy; Ravindra Kallappa; Shankar Achar Somashekar; Deepa Patil; Umakant N Patil
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 3.  Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.

Authors:  Jamie D Croxtall; Greg L Plosker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle.

Authors:  Rudy Susilo; Hans C Korting; Uwe Phillip Strauss
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 5.  Conazoles.

Authors:  Jan Heeres; Lieven Meerpoel; Paul Lewi
Journal:  Molecules       Date:  2010-06-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.